Results 1 to 10 of about 462,772 (320)
Dysregulation of myddosome complex genes its related to alendronate treatment failure in osteoporosis postmenopausal patients. [PDF]
Genet Mol BiolSome patients with osteoporosis (OP) do not respond to treatment with bisphosphonates; pathways that stimulate osteoclatogenesis may be involved in this failure, such as the myddosome pathway.
Oliveira BMR +5 more
europepmc +2 more sources
Three Classes of Antioxidant Defense Systems and the Development of Postmenopausal Osteoporosis
Frontiers in Physiology, 2022 Osteoporosis is a common bone imbalance disease that threatens the health of postmenopausal women. Estrogen deficiency accelerates the aging of women. Oxidative stress damage is regarded as the main pathogenesis of postmenopausal osteoporosis.
Keda Yang +4 more
doaj +2 more sources
The prevalence and treatment rate trends of osteoporosis in postmenopausal women.
PLoS ONE, 2023 BackgroundTo evaluate the prevalence and treatment of postmenopausal women with osteoporosis in recent years, analyze differences between the prevalence diagnosed by physicians and the prevalence detected by bone mineral density (BMD), and observe the ...
Xiaojuan Zhang +6 more
doaj +2 more sources
Frontiers in Pharmacology, 2023 Osteoporosis and periodontitis are two major chronic diseases of postmenopausal women. The association between these two diseases are evident through systemic bone loss and alveolar bone loss.
Putri Ayu Jayusman +5 more
doaj +2 more sources
PLoS ONE, 2021 Osteoporosis is the most common disease of the musculoskeletal system in old age. Therefore, research on osteoporosis risk factors is actively being conducted.
Min Hyeok Choi +4 more
doaj +2 more sources
Frontiers in Endocrinology, 2023 IntroductionThe risk of fragility fractures is increased in patients with type 2 diabetes mellitus (T2DM). Many reports indicate that inflammatory and immune responses are associated with osteoporosis and osteopenia. The monocyte-to-lymphocyte ratio (MLR)
Hailin Li +6 more
doaj +1 more source
All Life, 2023 This study aimed to examine metabolites in the plasma derived from postmenopausal women by untargeted metabolomics along with possible diagnostic markers for osteoporosis.
Kun Zhu +5 more
doaj +1 more source
Journal of the Formosan Medical Association, 2023 Postmenopausal women are at significant risk for osteoporotic fractures due to their rapid bone loss. Half of all postmenopausal women will get an osteoporosis-related fracture over their lifetime, with 25% developing a spine deformity and 15% developing
Chun-Feng Huang +25 more
doaj +1 more source
Postmenopausal osteoporosis coexisting with sarcopenia: the role and mechanisms of estrogen.
Journal of Endocrinology, 2023 Estrogens (estradiol, estriol, and estrone) are important hormones that directly and indirectly regulate the metabolism and function of bone and skeletal muscle via estrogen receptors.
Lingyun Lu, L. Tian
semanticscholar +1 more source
Identification of miR-194-5p as a potential biomarker for postmenopausal osteoporosis [PDF]
PeerJ, 2015 The incidence of osteoporosis is high in postmenopausal women due to altered estrogen levels and continuous calcium loss that occurs with aging. Recent studies have shown that microRNAs (miRNAs) are involved in the development of osteoporosis.
Jia Meng +8 more
doaj +2 more sources